*Sara Tolaney¹ (1. Associate Director for the Susan F. Smith Center for Women’s Cancers,Director of Clinical Trials in the Breast Oncology Center,Director of Breast Immunotherapy Clinical Research,Senior Physician at Dana-Farber Cancer Institute Associate Professor of Medicine at Harvard Medical School)